News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,300 Results
Type
Article (5566)
Company Profile (45)
Press Release (91689)
Section
Business (26016)
Career Advice (282)
Deals (3943)
Drug Delivery (10)
Drug Development (18344)
Employer Resources (17)
FDA (2471)
Job Trends (1964)
News (49965)
Policy (3801)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (360)
Accelerated approval (1)
Adcomms (4)
Allergies (21)
Alliances (7779)
ALS (25)
Alzheimer's disease (286)
Antibody-drug conjugate (ADC) (17)
Approvals (2490)
Artificial intelligence (24)
Autoimmune disease (4)
Automation (2)
Bankruptcy (22)
Best Places to Work (1680)
BIOSECURE Act (2)
Biosimilars (15)
Biotechnology (33)
Bladder cancer (11)
Brain cancer (9)
Breast cancer (53)
Cancer (407)
Cardiovascular disease (33)
Career advice (240)
Career pathing (4)
CAR-T (32)
Cell therapy (88)
Cervical cancer (2)
Clinical research (15207)
Collaboration (172)
Compensation (51)
Complete response letters (3)
COVID-19 (389)
CRISPR (15)
C-suite (30)
Cystic fibrosis (15)
Data (574)
Denatured (3)
Depression (9)
Diabetes (33)
Diagnostics (968)
Digital health (1)
Diversity, equity & inclusion (3)
Drug discovery (26)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (34)
Earnings (9037)
Editorial (5)
Employer branding (3)
Employer resources (17)
Events (14551)
Executive appointments (106)
FDA (2725)
Featured Employer (4)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (125)
Gene editing (30)
Generative AI (1)
Gene therapy (68)
GLP-1 (92)
Government (486)
Guidances (4)
Healthcare (2053)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (20)
Indications (13)
Infectious disease (408)
Inflammatory bowel disease (44)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (21)
Interviews (50)
IPO (1912)
IRA (7)
Job creations (377)
Job search strategy (209)
Kidney cancer (8)
Labor market (4)
Layoffs (50)
Leadership (3)
Legal (418)
Liver cancer (11)
Lung cancer (63)
Lymphoma (34)
Management (7)
Manufacturing (44)
MASH (15)
Medical device (953)
Medtech (953)
Mergers & acquisitions (2123)
Metabolic disorders (91)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (20)
Neuropsychiatric disorders (5)
Neuroscience (428)
NextGen: Class of 2025 (789)
Non-profit (420)
Northern California (573)
Now hiring (6)
Obesity (41)
Opinion (36)
Ovarian cancer (20)
Pain (17)
Pancreatic cancer (14)
Parkinson's disease (31)
Partnered (2)
Patents (36)
Patient recruitment (20)
Peanut (16)
People (7885)
Pharmaceutical (6)
Phase I (4716)
Phase II (6863)
Phase III (5135)
Pipeline (192)
Podcasts (4)
Policy (12)
Postmarket research (421)
Preclinical (1999)
Press Release (8)
Prostate cancer (8)
Psychedelics (5)
Radiopharmaceuticals (45)
Rare diseases (103)
Real estate (654)
Recruiting (9)
Regulatory (3317)
Reports (8)
Research institute (422)
Resumes & cover letters (35)
Rett syndrome (1)
RNA editing (1)
RSV (4)
Schizophrenia (27)
Series A (27)
Series B (10)
Service/supplier (3)
Sickle cell disease (10)
Southern California (520)
Special edition (1)
Spinal muscular atrophy (52)
Sponsored (4)
Startups (700)
Stomach cancer (1)
Supply chain (9)
The Weekly (1)
United States (4017)
Vaccines (78)
Venture capitalists (9)
Webinars (3)
Weight loss (20)
Women's health (1)
Worklife (1)
Date
Today (10)
Last 7 days (129)
Last 30 days (571)
Last 365 days (6930)
2025 (1371)
2024 (7159)
2023 (7797)
2022 (9582)
2021 (9911)
2020 (8460)
2019 (6425)
2018 (4608)
2017 (5150)
2016 (4562)
2015 (5268)
2014 (3601)
2013 (2857)
2012 (3000)
2011 (3055)
2010 (2809)
Location
Africa (98)
Alabama (1)
Alaska (1)
Arizona (15)
Arkansas (3)
Asia (5496)
Australia (849)
California (1309)
Canada (321)
China (84)
Colorado (50)
Connecticut (57)
Delaware (27)
Europe (14143)
Florida (108)
Georgia (23)
Idaho (7)
Illinois (55)
India (3)
Indiana (52)
Japan (31)
Kansas (55)
Kentucky (2)
Louisiana (1)
Maine (3)
Maryland (149)
Massachusetts (798)
Michigan (46)
Minnesota (32)
Missouri (7)
Montana (2)
Nebraska (3)
Nevada (12)
New Hampshire (8)
New Jersey (256)
New Mexico (3)
New York (236)
North Carolina (228)
North Dakota (2)
Northern California (573)
Ohio (45)
Oklahoma (3)
Oregon (8)
Pennsylvania (198)
Rhode Island (4)
South America (99)
South Carolina (1)
Southern California (520)
Tennessee (9)
Texas (164)
Utah (20)
Virginia (17)
Washington D.C. (2)
Washington State (112)
Wisconsin (10)
97,300 Results for "character biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
January 10, 2025
·
2 min read
Business
Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief Scientific Officer
Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer.
September 13, 2023
·
2 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Arcus Biosciences to Participate in Two Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Aura Biosciences to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - February 24, 2025
February 25, 2025
·
1 min read
Press Releases
Neurocrine Biosciences Presents 48-Week Remission Data on Treatment of Tardive Dyskinesia With INGREZZA® (valbenazine) Capsules
March 20, 2025
·
12 min read
Press Releases
Enveric Biosciences Participating in BIO-Europe Spring®
March 18, 2025
·
4 min read
Press Releases
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
March 18, 2025
·
10 min read
Press Releases
Alafair Biosciences Reports Strong Growth in 2024
March 6, 2025
·
3 min read
1 of 9,730
Next
